Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRA-EVO Trial: Evolocumab vs Standard Therapy on Plaque Progression in ACS
NCT07612774Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in acute coronary syndrome (ACS), sponsored by West China Hospital of Sichuan University. Started Nov 2025; status: recruiting.
02
Drugs
evolocumab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07612774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612774.